نتایج جستجو برای: chlorotoxin like peptide

تعداد نتایج: 792662  

2013
Pedro M Costa Ana L Cardoso Liliana S Mendonça Angelo Serani Carlos Custódia Mariana Conceição Sérgio Simões João N Moreira Luís Pereira de Almeida Maria C Pedroso de Lima

The present work aimed at the development and application of a lipid-based nanocarrier for targeted delivery of nucleic acids to glioblastoma (GBM). For this purpose, chlorotoxin (CTX), a peptide reported to bind selectively to glioma cells while showing no affinity for non-neoplastic cells, was covalently coupled to liposomes encapsulating antisense oligonucleotides (asOs) or small interfering...

Journal: :Cell Communication and Signaling 2019

Journal: :Experimental Diabetes Research 2011

Journal: :Journal of Diabetes and its Complications 2016

2016
Charles F. Shaefer

In Brief In the past decade, various incretin-based therapies have emerged in clinical practice. These drugs, including dipeptidyl peptidase-4 inhibitors and glucagon-like peptide 1 (GLP-1) receptor agonists lower A1C with weight-neutral or weight-lowering effects and a relatively lower risk of hypoglycemia. This article provides a review of lixisenatide, a once-daily GLP-1 receptor agonist for...

Journal: :Diabetes care 2014
Stanley Schwartz Ralph A Defronzo

We thank Drs. Deane and Horowitz (1) for bringing this work to our attention. Their results provide further support for our contention that glucagon-like peptide 1 (GLP-1) therapy represents a safe and effective intervention to improve glycemic control in critically ill, hospitalized patients both with and without preexisting type 2 diabetes. In agreement with us (2), they recognize that “insul...

Journal: :Physiology 2005
Elaine M Sinclair Daniel J Drucker

Glucagon is used for the treatment of hypoglycemia, and glucagon receptor antagonists are under development for the treatment of type 2 diabetes. Moreover, glucagon-like peptide (GLP)-1 and GLP-2 receptor agonists appear to be promising therapies for the treatment of type 2 diabetes and intestinal disorders, respectively. This review discusses the physiological, pharmacological, and therapeutic...

Journal: :Current pharmaceutical design 2011
Mark R Stroud Stacey J Hansen James M Olson

Surgical resection remains the primary component of cancer therapy. The precision required to successfully separate cancer tissue from normal tissue relies heavily on the surgeon's ability to delineate the tumor margins. Despite recent advances in surgical guidance and monitoring systems, intra-operative identification of these margins remains imprecise and directly influences patient prognosis...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید